Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanye Tongzhiqing Tablets is an investigational Traditional Chinese Medicine (TCM) formulation developed by Tianjin University of Traditional Chinese Medicine. It is primarily being evaluated for the treatment of type 2 diabetes mellitus, specifically targeting patients with the "phlegm-turbidity and blood stasis" pattern according to TCM diagnostics. The drug is designed to improve glycemic control and metabolic parameters, and it has been studied in Phase 2 clinical trials in China as both a monotherapy for treatment-naive patients and as an add-on therapy for those inadequately controlled on metformin. As a botanical-based product, its therapeutic effects are likely derived from the synergistic action of multiple active components found in its constituent herbs, which are intended to regulate lipid metabolism and insulin sensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanye Tongzhiqing Tablets (Tianjin University of Traditional Chinese Medicine).